FDA Approves MYCOPHENOLIC ACID — Slate Run Pharmaceuticals, LLC
Slate Run Pharmaceuticals, LLC announced the February 2021 approval of its ANDA for mycophenolic acid oral tablets, a biosimilar to the original immunosuppressant...
AI-generated summary for informational purposes only. Always verify against the original filing. Not investment advice. BriefTape is not a registered investment adviser.
Get real-time financial news in your trading bot or app
START FREE — 10,000 calls/day, no key needed